触发巨细胞的IgG4抗体触发了对整体蛋白αvβ3+的细胞毒性 癌症
Joshua P Reddy1, Ziqi Yu1, Ryan M Shepard1
1University of California, San Diego, La Jolla, CA, United States.
Molecular cancer therapeutics
|October 13, 2025
概括
重新设计抗αvβ3抗体以激活与瘤相关的巨细胞 (TAMs) 增强了抗瘤活性. 这种新的方法通过利用TAMs进行抗体介导治疗来准耐药癌症.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药物开发 药物开发
背景情况:
- 集成蛋白αvβ3是上皮癌的点,与瘤干和药物耐药性有关.
- 现有的抗αvβ3抗体 (例如,埃塔拉齐祖马布) 由于瘤微环境而存在局限性.
- 与瘤相关的巨细胞 (TAMs) 在αvβ3阳性瘤中很普遍,提供了潜在的治疗途径.
研究的目的:
- 为了重新设计抗αvβ3抗体以激活TAM介导的细胞毒性.
- 为了增强对整合素αvβ3阳性癌症的抗瘤活性.
- 探索一种新的基于抗体的癌症治疗策略.
主要方法:
- 开发了一种完全人类的IgG4变体 (anti-αvβ3 G4),具有优化的CD64激活在巨细胞上.
- 利用来自肺癌患者和老鼠异种移植的器官样本培养物进行测试.
- 研究了作用机制,包括CD64和诱导性氧化合成酶 (iNOS) 的上调.
主要成果:
- 与IgG1版本相比,抗αvβ3 G4显示出更强的抗瘤活性.
- 增强的疗效归因于TAMs中的CD64激活.
- TAM激活导致iNOS增加,这对于免疫效应因子中介的细胞毒性至关重要.
结论:
- 重新设计抗体以向TAM是对攻击性,耐药性癌症的有效策略.
- Fc开关方法为向TAM丰富的瘤提供了广泛的适用性.
- 这项研究强调了抗体介导癌症免疫疗法的有前途方向.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:27Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K